Other Species / Isoforms
  PIP4K2A (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T3-p
_____MAtPGNLGSs
Upstream
0 8
Treatment
  • MG132_withdrawal
PIP4K2A (human) _____MAtPGNLGSs T3-p
PIP4K2A (mouse) _____MAtPGNLGSs T3-p
PIP4K2A (rat) _____MATPSNLGSS T3
S10-p
tPGNLGSsVLAskTK
0 3
PIP4K2A (human) tPGNLGSsVLAskTK S10-p
PIP4K2A (mouse) tPGNLGSsVLAsKTK S10-p
PIP4K2A (rat) TPSNLGSSVLASKTK S10
S14-p
LGSsVLAskTKTKKK
Upstream
0 9
Treatment
  • MG132_withdrawal
  • nocodazole
PIP4K2A (human) LGSsVLAskTKTKKK S14-p
PIP4K2A (mouse) LGSsVLAsKTKTKKK S14-p
PIP4K2A (rat) LGSSVLASKTKTKKK S14
K15-ub
GSsVLAskTKTKKKH
0 1
PIP4K2A (human) GSsVLAskTKTKKKH K15-ub
PIP4K2A (mouse) GSsVLAsKTKTKKKH K15
PIP4K2A (rat) GSSVLASKTKTKKKH K15
K27-ub
KKHFVAQkVKLFRAS
0 1
PIP4K2A (human) KKHFVAQkVKLFRAS K27-ub
PIP4K2A (mouse) KKHFVAQKVKLFRAS K27
PIP4K2A (rat) KKHFVAQKVKLFRAS K27
K81-ub
VDNHLFNkENMPSHF
0 2
PIP4K2A (human) VDNHLFNkENMPSHF K81-ub
PIP4K2A (mouse) VDNHLFNkENMPSHF K81-ub
PIP4K2A (rat) VDNHLFNKENMPSHF K81
K89-ac
ENMPSHFkFkEyCPM
0 3
PIP4K2A (human) ENMPSHFkFkEyCPM K89-ac
PIP4K2A (mouse) ENMPSHFkFkEyCPM K89-ac
PIP4K2A (rat) ENMPSHFkFKEYCPM K89-ac
K89-ub
ENMPSHFkFkEyCPM
0 1
PIP4K2A (human) ENMPSHFkFkEyCPM K89-ub
PIP4K2A (mouse) ENMPSHFKFkEyCPM K89
PIP4K2A (rat) ENMPSHFKFKEYCPM K89
K89-m1
ENMPSHFkFkEyCPM
0 1
PIP4K2A (human) ENMPSHFkFkEyCPM K89-m1
PIP4K2A (mouse) ENMPSHFKFkEyCPM K89
PIP4K2A (rat) ENMPSHFKFKEYCPM K89
K91-ub
MPSHFkFkEyCPMVF
0 2
PIP4K2A (human) MPSHFkFkEyCPMVF K91-ub
PIP4K2A (mouse) MPSHFkFkEyCPMVF K91-ub
PIP4K2A (rat) MPSHFkFKEYCPMVF K91
K91-m1
MPSHFkFkEyCPMVF
0 1
PIP4K2A (human) MPSHFkFkEyCPMVF K91-m1
PIP4K2A (mouse) MPSHFkFKEyCPMVF K91
PIP4K2A (rat) MPSHFkFKEYCPMVF K91
Y93-p
SHFkFkEyCPMVFRN
0 34
PIP4K2A (human) SHFkFkEyCPMVFRN Y93-p
PIP4K2A (mouse) SHFkFkEyCPMVFRN Y93-p
PIP4K2A (rat) SHFkFKEYCPMVFRN Y93
K145-ac
YDKRYIIkTITSEDV
0 1
PIP4K2A (human) YDKRYIIkTITSEDV K145-ac
PIP4K2A (mouse) YDKRYVIKTITSEDV K145
PIP4K2A (rat) YDKRYVIKTITSEDV K145
K145-ub
YDKRYIIkTITSEDV
0 1
PIP4K2A (human) YDKRYIIkTITSEDV K145-ub
PIP4K2A (mouse) YDKRYVIKTITSEDV K145
PIP4K2A (rat) YDKRYVIKTITSEDV K145
K160
AEMHNILKKYHQYIV
0 1
PIP4K2A (human) AEMHNILKKYHQYIV K160
PIP4K2A (mouse) AEMHNILkKYHQYIV K160-ub
PIP4K2A (rat) AEMHNILKKYHQYIV K160
K244-ub
DFINEGQkIyIDDNN
0 1
PIP4K2A (human) DFINEGQkIyIDDNN K244-ub
PIP4K2A (mouse) DFINEGQKIYIDDNN K244
PIP4K2A (rat) DFINEGQKIYIDDSN K244
Y246-p
INEGQkIyIDDNNKK
0 2
PIP4K2A (human) INEGQkIyIDDNNKK Y246-p
PIP4K2A (mouse) INEGQKIYIDDNNKK Y246
PIP4K2A (rat) INEGQKIYIDDSNKK Y246
S304-p
DGEEEGEsDGTHPVG
Upstream
Downstream
1 0
Effects on Modified Protein
  • intracellular localization
Kinase, in vitro:
  • CK2A1 (human)
Putative in vivo kinases:
  • CK2A1 (human)
PIP4K2A (human) DGEEEGEsDGTHPVG S304-p
PIP4K2A (mouse) DGEEEGESDSTHPIG S304
PIP4K2A (rat) EGEEEGESDGAHPIG S304
K367-ac
ILTHYDAkKKAAHAA
0 11
PIP4K2A (human) ILTHYDAkKKAAHAA K367-ac
PIP4K2A (mouse) ILTHYDAKKKAAHAA K367
PIP4K2A (rat) ILTHYDAKKKAAHAA K367
T376-p
KAAHAAKtVKHGAGA
Upstream
Downstream
1 0
Effects on Modified Protein
  • enzymatic activity, inhibited
Kinase, in vitro:
  • PRKD1 (human)
Putative in vivo kinases:
  • PRKD1 (human)
Treatment
  • Go_6976
  • H2O2
PIP4K2A (human) KAAHAAKtVKHGAGA T376-p
PIP4K2A (mouse) KAAHAAKTVKHGAGA T376
PIP4K2A (rat) KAAHAAKTVKHGAGA T376